CAUSEWAY SENSORS LIMITED

Active United Kingdom

Manufacture of optical precision instruments

15 employees website.com
Life sciences and medical technology Manufacture of optical precision instruments
C

CAUSEWAY SENSORS LIMITED

Manufacture of optical precision instruments

Founded 17 Jun 2013 Active United Kingdom 15 employees website.com
Life sciences and medical technology Manufacture of optical precision instruments
Accounts Submitted 1 Apr 2026 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 1 Jul 2025 Next due 1 Jul 2026 1 month remaining
Net assets £-1M £430K 2025 year on year
Total assets £713K £499K 2025 year on year
Total Liabilities £2M £69K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for CAUSEWAY SENSORS LIMITED (NI618921), an active life sciences and medical technology company based in United Kingdom. Incorporated 17 Jun 2013. Manufacture of optical precision instruments. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2014–2025)

Cash in Bank

£451.70k

Decreased by £348.63k (-44%)

Net Assets

-£1.27M

Decreased by £429.64k (-51%)

Total Liabilities

£1.98M

Decreased by £69.45k (-3%)

Turnover

N/A

Employees

15

Increased by 2 (+15%)

Debt Ratio

278%

Increased by 109 (+64%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 1

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 5Jun 2016Seed
Investor 1Mar 2018Unknown/Other
Investor 2Mar 2018Unknown/Other

Officers

Officers

2 active 1 resigned
Status
Robert James PollardDirectorBritishNorthern Ireland6217 Jun 2013Active
Tara DaltonDirectorIrishIreland551 Jul 2019Active

Shareholders

Shareholders (6)

Bank Of Ireland Kernel Capital Growth Fund (ni)
74.4%
Qubis Limited
16.1%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 3 Jun 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

KERNEL CAPITAL BELFAST united kingdom
CAUSEWAY SENSORS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 Apr 2026AccountsAnnual accounts made up to 30 Jun 2025
7 Jan 2026OfficersAppointment of Dr Robert Mark Blenkinsopp as director on 1 Jan 2026
6 Jan 2026OfficersTermination of William David John Moore as director on 31 Dec 2025
1 Jul 2025Confirmation StatementConfirmation statement made on 17 Jun 2025 with no updates
6 Mar 2025OfficersTermination of Deirdre Francis as director on 6 Mar 2025
1 Apr 2026 Accounts

Annual accounts made up to 30 Jun 2025

7 Jan 2026 Officers

Appointment of Dr Robert Mark Blenkinsopp as director on 1 Jan 2026

6 Jan 2026 Officers

Termination of William David John Moore as director on 31 Dec 2025

1 Jul 2025 Confirmation Statement

Confirmation statement made on 17 Jun 2025 with no updates

6 Mar 2025 Officers

Termination of Deirdre Francis as director on 6 Mar 2025

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

1 months ago on 1 Apr 2026

Appointment of Dr Robert Mark Blenkinsopp as director on 1 Jan 2026

3 months ago on 7 Jan 2026

Termination of William David John Moore as director on 31 Dec 2025

3 months ago on 6 Jan 2026

Confirmation statement made on 17 Jun 2025 with no updates

10 months ago on 1 Jul 2025

Termination of Deirdre Francis as director on 6 Mar 2025

1 years ago on 6 Mar 2025